Relevance of hepatitis B core gene deletions in patients after kidney transplantation

被引:25
作者
Bock, CT
Buerke, B
Tillmann, HL
Tacke, F
Kliem, V
Manns, MP
Trautwein, C
机构
[1] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Nephrol, D-30625 Hannover, Germany
关键词
D O I
10.1016/S0016-5085(03)00396-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Hepatitis B virus (HBV) infection is a major cause of death in the long-term follow-up after organ transplantation and immunosuppressive therapy. The selection pressure on the HBV genome in these patients is reduced. The aim was to analyze and characterize variations in the HBV core gene after organ transplantation and their impact for prognosis. Methods: In patients with chronic HBV infection after organ transplantation (liver, n = 60; heart, n = 50; kidney, n = 30) the HBV core gene was amplified by polymerase chain reaction (PCR), Core gene deletions were cloned into replication competent and expression vectors. The impact of these mutations on HBV replication and capsid formation was analyzed and correlated with disease progression. Results: Central core gene deletions only were detected in patients after kidney transplantation. Two types of core gene deletions-small and large-were found. Large core gene deletions showed no capsid formation and HBV replication, which resulted in nuclear core expression. The occurrence of large core gene deletions was associated with a severe course of liver disease. Conclusions: Core gene deletions occur specifically after kidney transplantation. Only large core gene deletions resulted in impaired capsid formation and nuclear localization of the core protein. The presence of large core gene deletions was associated with progressive disease.
引用
收藏
页码:1809 / 1820
页数:12
相关论文
共 38 条
[31]   Dominant negative mutants of the duck hepatitis B virus core protein interfere with RNA pregenome packaging and viral DNA synthesis [J].
von Weizsäcker, F ;
Köck, J ;
Wieland, S ;
Offensperger, WB ;
Blum, HE .
HEPATOLOGY, 1999, 30 (01) :308-315
[32]   Long-term outcome of chronic hepatitis B in heart transplant recipients [J].
Wedemeyer, H ;
Pethig, K ;
Wagner, D ;
Flemming, P ;
Oppelt, P ;
Petzold, DR ;
Haverich, A ;
Manns, MP ;
Boeker, KHW .
TRANSPLANTATION, 1998, 66 (10) :1347-1353
[33]   Cyclosporin as baseline immunosuppression in solid organ transplantation [J].
Winkler, M .
BIODRUGS, 2000, 14 (03) :185-193
[34]   Long-term outcome of renal transplantation in hepatitis B surface antigen-positive patients in cyclosporin era [J].
Yagisawa, T ;
Toma, H ;
Tanabe, K ;
Ishikawa, N ;
Tokumoto, N ;
Iguchi, Y ;
Goya, N ;
Nakazawa, H ;
Takahashi, K ;
Ota, K .
AMERICAN JOURNAL OF NEPHROLOGY, 1997, 17 (05) :440-444
[35]   Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years [J].
Younossi, ZM ;
Braun, WE ;
Protiva, DA ;
Gifford, RW ;
Straffon, RA .
TRANSPLANTATION, 1999, 67 (02) :272-275
[36]   Functional characterization of naturally occurring variants of human hepatitis B virus containing the core internal deletion mutation [J].
Yuan, TTT ;
Lin, MH ;
Qiu, SM ;
Shih, CH .
JOURNAL OF VIROLOGY, 1998, 72 (03) :2168-2176
[37]  
ZHENG J, 1992, J BIOL CHEM, V267, P9422
[38]   Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein [J].
Zlotnick, A ;
Cheng, N ;
Conway, JF ;
Booy, FP ;
Steven, AC ;
Stahl, SJ ;
Wingfield, PT .
BIOCHEMISTRY, 1996, 35 (23) :7412-7421